Genvec News
Most Popular Genvec Story
ALSO NOTED: Generic Plavix grabs big market share; Medarex to collaborate on antibodies; and much more...
> The generic version of Plavix has already claimed slightly more than 60 percent of the total market for the drug and 74 percent of all new prescriptions. In court testimony yesterday a financial expert hired by Apotex says that if the generic drug maker loses its fight to continue selling the drug, it would cost the company $4 billion. Report
> Medarex and Germany's GenPat77 Pharmacogenetics will …
... Read more...Latest Headlines
- December 18, 2006
- October 10, 2006
- August 22, 2006
- August 15, 2006
- February 14, 2006
- July 26, 2005
- June 14, 2005
- May 24, 2005
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
